Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CVKD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CVKD investment potential.

What is CVKD stock price today?

Get real-time CVKD stock price, historical data, and price charts on Financhill. Track CVKD performance with our advanced analysis tools.

Is CVKD a good investment?

Evaluate CVKD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CVKD stock?

To buy CVKD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CVKD?

View detailed market capitalization data and company valuation metrics for CVKD on our comprehensive analysis page.

What is the P/E ratio of CVKD?

Use our fundamental analysis tools to view CVKD P/E ratio and compare valuation metrics with industry peers.

What are CVKD earnings?

View CVKD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cadrenal Therapeutics, Inc. Stock Predictions

Get Your Free Stock Selector Checklist and Invest Smarter

Get Your Free Safe Stock Selector Checklist Now

Sell

CVKD
Cadrenal Therapeutics, Inc.

Last Price:

$9.90

Seasonality Move:

23.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Safe Investing Checklist - Stay Clear of Risky Stocks

Get Your Free Safe Stock Selector Checklist Now

Cadrenal Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Cadrenal Therapeutics, Inc. has on average historically risen by 30.5% based on the past 2 years of stock performance.
Cadrenal Therapeutics, Inc. has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Cadrenal Therapeutics, Inc. Stock Undervalued?

The current Cadrenal Therapeutics, Inc. [CVKD] share price is $10.18. The Score for CVKD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
CVKD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cadrenal Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Cadrenal Therapeutics, Inc. has on average historically risen by 30.5% based on the past 2 years of stock performance.

Cadrenal Therapeutics, Inc. Stock Rating

Sell

Cadrenal Therapeutics, Inc. (CVKD) is a Sell

Is Cadrenal Therapeutics, Inc. overpriced?

Cadrenal Therapeutics, Inc. has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Cadrenal Therapeutics, Inc. Stock Price History

Is CVKD stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVKD is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

cadrenal.com

52-Week Data

52-Week High:

22.90

52-Week Low:

8.12

Prediction Charts

Market Cap:

21.1M

Price in USD:

10.18

Volume:

38.4K

Beta:

1.05

Technical Analysis

SMA50:

12.38

SMA100:

12.32

SMA200:

13.95

52-Wk Change:

-23.86%

Stock Predictions

Is Cadrenal Therapeutics, Inc. stock public?

Yes, Cadrenal Therapeutics, Inc. is a publicly traded company.
What is the Cadrenal Therapeutics, Inc. stock quote today?

The Cadrenal Therapeutics, Inc. stock price is 10.18 USD today.
How to buy Cadrenal Therapeutics, Inc. stock online?

You can buy Cadrenal Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	11.69	11.70	12.15	11.65
Nov-18	11.61	11.93	12.22	11.61
Nov-19	11.84	11.26	12.14	11.22
Nov-20	11.67	11.30	11.89	11.30
Nov-21	11.25	10.19	11.28	10.01
Nov-24	10.26	10.04	11.29	10.04
Nov-25	10.09	9.92	10.28	9.38
Nov-26	9.90	9.38	10.07	9.30
Nov-28	9.42	9.39	9.56	9.36
Dec-1	9.05	9.00	9.27	8.66
Dec-2	8.73	8.27	8.97	8.20
Dec-3	8.26	8.86	8.86	8.12
Dec-4	9.66	11.10	11.58	9.66
Dec-5	11.04	10.18	11.04	9.84

Cadrenal Therapeutics, Inc. Earnings

Cadrenal Therapeutics, Inc. Earnings Report: Per Share Cadrenal Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cadrenal Therapeutics, Inc. Forecast Revenue Growth

Cadrenal Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cadrenal Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $1.39 per share.

* Cadrenal Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.